Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque Psoriasis
Status:
Completed
Trial end date:
2018-10-22
Target enrollment:
Participant gender:
Summary
This study seeks to show whether there is a benefit of prescribing Enstilar with Otezla in
the treatment of patients with moderate plaque type psoriasis. Subjects will be randomized to
study treatment at a 1:1 ratio of Otezla plus Enstilar foam versus Otezla plus vehicle foam.